The Microalbuminuria Education Medication and Optimisation ( MEMO ) study: 4 years follow‐up of multifactorial intervention in high‐risk individuals with type 2 diabetes

Aims The Microalbuminuria Education Medication and Optimisation ( MEMO ) study, revealed improved cardiovascular risk and glycaemic control with 18 months of intensive multifactorial intervention in high‐risk people with type 2 diabetes, without any increase in severe hypoglycaemia. Our aim was to assess longer‐term outcomes at 4‐year follow‐up in these participants. Methods Some 189 individuals with type 2 diabetes and microalbuminuria were...